Bivin & Associates, Inc. Biolase, Inc Transaction History

Bivin & Associates, Inc.

  • $93.1 Million
  • Q2 2022

A detailed history of Bivin & Associates, Inc. transactions in Biolase, Inc stock. As of the latest transaction made, Bivin & Associates, Inc. holds 40 shares of BIOL stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$3.42 - $8.75 $136 - $350
40 New
40 $0

Others Institutions Holding BIOL

# of Institutions
2
Shares Held
56
Call Options Held
0
Put Options Held
0
View Full List

About BIOLASE, INC

BIOL Quotes by TradingView
  • Ticker BIOL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,260,180
  • Market Cap $82.6K
  • Description
  • BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive de...
More about BIOL
Track This Portfolio

Track Bivin & Associates, Inc. Portfolio

Follow Bivin & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bivin & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bivin & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email